CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Amyris Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Amyris Inc
5885 Hollis St Ste 100
Phone: (510) 450-0761p:510 450-0761 EMERYVILLE, CA  94608-2405  United States Fax: (510) 225-2645f:510 225-2645
Emerged from Bankruptcy on 5/7/2024
This company ceased filing statements with the SEC on 5/7/2024.
This company is no longer actively traded on any major stock exchange.
Business Summary
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202312/31/2022YesYesYes-Yes

Industries
SIC Code Description
2869 Industrial organic chemicals, not elsewhere classified
2865 Cyclic organic crudes and intermediates, and organic dyes and pigments
2899 Chemicals and chemical preparations, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Interim Chairman of the Board Geoffrey M.Duyk 63 5/1/2014 5/1/2006
Interim Chief Executive Officer, Chief Financial Officer, Chief Administrative Officer HanKieftenbeld 58 7/3/2023 3/16/2020
General Counsel, Secretary DorisChoi 44 12/16/2022 12/16/2022
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Amyris Clean Beauty, Inc. 5885 Hollis Street Emeryville CA United States
Amyris Fuels, LLC 5885 Hollis Street Emeryville CA United States
Amyris-Olika, LLC 5885 Hollis Street Emeryville CA United States
6 additional Subsidiary records available in full report.

Business Names
Business Name
AB Technologies LLC
AB Technologies LLC
Accessbio LLC
37 additional Business Names available in full report.

General Information
Number of Employees: 1,598 (As of 12/31/2022)
Outstanding Shares: 369,385,614 (As of 5/5/2023)
Shareholders: 166
Stock Exchange: OTC
Federal Tax Id: 550856151
Fax Number: (510) 225-2645


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 9, 2024